Figure 4.
The performance of ML-based TSR with a 45.7% cut-off point in predicting prognosis in the TCGA cohort. Kaplan–Meier survival curves for the following subgroups: (A) age ≥ 70; (B) male; (C) female; (D) high histologic grade; (E) lymphovascular invasion; (F) pT stage 3–4; (G) pN stage 0–1; (H) pM stage 0; (I) pTNM stage III-IV.